Home » Newsletters » BioWorld Science

BioWorld Science

June 20, 2002

View Archived Issues

Novel COX-2 inhibitors in early development at GSK

Tachykinin antagonists for use in depression and other disorders

Synthesis of novel 5-HT2A receptor ligands reported at Medicinal Chemistry Symposium

Abbott identifies aryl tetrahydropyridine farnesyltransferase inhibitors

Biological activity of paclitaxel-glucose conjugate tested in human cancer cell lines

Discovery of CCR3 receptor antagonists with potential in allergic asthma

Novel antiinflammatory agents from Celgene act by inhibiting transcriptional activation in T-cells

A wealth of data on lumiracoxib presented at the EULAR congress

NN-2211 may be useful for treating obesity and type 2 diabetes

Preclinical findings reported for aldose reductase inhibitor fidarestat

New data on ragaglitazar discussed at the ADA scientific sessions

Lead PTP1B inhibitor with blood glucose-lowering effects identified by Korean group

Hydroxamate-based antibiotics targeting LpxC in Gram-negative bacteria

DISC-GMCSF completes phase I study

NDA filing for Purdue's abuse-resistant pain medication delayed

FSME-IMMUN vaccine approved for adult use in Germany

Chiron grants nonexclusive HCV license to Merck & Co.

Argenta Discovery and Amedis enter drug discovery collaboration

Immtech's lead hepatitis C compounds to be validated for further development

Trospium completes phase III trial in overactive bladder

CoFactor phase II trial design finalized

Asthma drug candidate selected under Texas Biotechnology/Schering-Plough collaboration

Frova launched in U.S.

Human 5-HT2C receptor ligands selected for further evaluation at Vernalis for use in obesity

Sankyo patents new antitumor compounds

3-Dimensional presents new trypsin-like protease inhibitors in recent patent

Potent inhibitors of IL-12 production and potential therapeutic applications

Mast cell stabilizers synthesized at Alcon active in model of allergic conjunctivitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...